LRP8 and lung cancer: In addition, in lung cancer, miR-30b-5p overexpression could inhibit the progression of lung cancer and enhances cisplatin sensitivity through targeting low-density lipoprotein receptor-related protein 8 [13] and miR-30b-5p functions as a metastasis suppressor in CRC by targeting Rap1b [14].